Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners In-licensing of four clinical-stage product candidates to treat orphan neurological disordersHighly experienced team leverages latest scientific discoveries in neuroscienceFinancing will advance the...